Objectives Objectives: Study effects of two limit-fed diets formulated to provide two levels of dietary energy and offered at two different intake rates to target similar gains and analyze the efficacy of a novel DNAimmunostimulant administered on arrival.
Introduction
Limit-feeding high-energy diets based primarily on wet corn gluten feed has been shown to significantly increase efficiency in growing cattle. A trial conducted recently at the Beef Stocker Unit utilized a diet offered ad libitum to determine the amount of feed offered in the limit-fed diets. Results demonstrated significantly improved performance. However, in a production setting, the producer would not feed one diet to determine the level of feed offered for a separate diet. In order to utilize this programmed feeding strategy, specific levels of intake would need to be known without the use of a highroughage, low-energy, control diet to achieve desired gains. In addition, Zelnate-a novel DNA-immunostimulant-had not been previously analyzed under these dietary conditions to determine its effects on cattle health and performance.
Experimental Procedures
A total of 370 Angus × Brahman heifers were assembled from a single source in central Florida and shipped to the Kansas State University Beef Stocker Unit, Manhattan, KS, (1,455 mi) over a 2-day period from August 11 to 12, 2016 (2 loads each day). The heifers were used to validate results observed in an earlier experiment conducted at the Beef Stocker Unit involving high-energy limit-fed receiving diets based primarily on wet corn gluten feed and the use of a novel DNA-immunostimulant technology injected intramuscularly at the time of arrival processing (Zelnate, Bayer Animal Health, Shawnee Mission, KS). The two experimental diets were formulated to provide 50 or 60 Mcal net energy for gain/100 lb dry matter offered at 2.2 and 2.4% of body weight daily, respectively (Table 1 ). In addition, 1 of 2 arrival management protocols were implemented where animals did or did not receive Zelnate on day 0 in a 2 × 2 factorial arrangement of treatments. Treatment diets were fed for 42 days, then all animals were switched to the 50 Mcal net energy for gain/100 lb dry matter fed for ad libitum intake for 2 weeks to equalize gastrointestinal tract fill. Individual animal weights were measured on days 0, 14, and on conclusion of the trial (day 56). A pen scale was used on days 28 and 42. Feed delivery was adjusted based on updated cattle weights measured at each weigh period on a pen basis.
Results and Discussion
Despite extremely low intakes early in the receiving period, cattle were relatively healthy with 2 animals being pulled within the first two weeks after arrival for malnutrition. Of the animals pulled, both were from the high-energy/Zelnate treatment but most likely succumbed to issues not related to diet considering their lack of eating and overall stress endured by duration of transport.
Performance data can be found in Table 2 . Neither the use of Zelnate on arrival nor the interaction of diet and Zelnate had an affect on the performance or health parameters measured in this trial. Dietary treatment affected dry matter intake throughout the trial by design, as intakes were limited to specific percentages of average body weight in the pen daily (P=0.01). Average daily gain was not affected by dietary treatment, validating the results from the prior experiment conducted at the Beef Stocker Unit where these prescribed intakes were extrapolated (P=0.75). Because similar gains were achieved while varying the amount of feed delivered, efficiency (gain to feed ratio) was affected by dietary treatment yielding the high-energy, most restricted diet as the more efficient feeding strategy (P=0.03).
Implications
Limit-feeding a diet formulated to supply 60 Mcal net energy for gain/100 lb dry matter at 2.2% of body weight to target similar average daily gain is a more efficient feeding strategy than offering a higher-roughage, lower-energy diet at 2.4% of body weight to achieve similar gain. The use of Zelnate did not have an effect on any of the parameters measured in this trial. 
